{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T07:51:59Z","timestamp":1782633119427,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with chronic kidney disease (CKD) are at an increased risk choledocholithiasis, requiring intervention with endoscopic retrograde cholangiopancreatography (ERCP). Data on ERCP-related adverse events in this population is limited, hence this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study utilized the TriNetX database to assess the odds of ERCP-related adverse events in patients with stages 4 and 5 chronic kidney disease, as well as end-stage renal disease (ESRD) on dialysis. Primary outcomes were ERCP-related pancreatitis (PEP), bleeding, cholangitis, and perforation. Secondary outcomes were failure to extubate\/new post-procedure intubation, intensive care unit (ICU) admissions, and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After propensity score matching, our study included 4450 patients in the aCKD cohort and 4450 patients in the matched control cohort who underwent ERCP. Patients with aCKD had an increased odds of bleeding (OR 2.1, p\u2009&lt;\u20090.001), cholangitis (OR 1.6, p\u2009&lt;\u20090.001), ICU admissions (OR 2.2, p\u2009&lt;\u20090.001), intubation (OR 3.0, p\u2009&lt;\u20090.001) and mortality (OR 1.8, p\u2009&lt;\u20090.001) compared to those with normal renal function. The odds of PEP (OR 1.1, p\u2009=\u20090.542) and perforation (OR 1.3, p\u2009=\u20090.528) were statistically similar between the two cohorts. No subgroup differences in ERCP-related AE were found except for increased ICU admissions odds in ESRD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>aCKD patients are a demonstrably high-risk group for certain ERCP-related AEs but not for PEP or perforation, a finding that may change the previous widespread perception of increased PEP risk in this population. Additional studies are needed to validate our findings and investigate potential interventions to improve clinical outcomes in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-025-12323-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:00:36Z","timestamp":1761152436000},"page":"404-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advanced chronic kidney disease increases the odds of ERCP adverse events but not post-ERCP pancreatitis: a propensity-matched analysis of the US Collaborative Network"],"prefix":"10.1007","volume":"40","author":[{"given":"Hussein","family":"Baydoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizullah","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Ramai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram R.","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin Said","family":"Dahbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Batarseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwala","family":"Pamidimukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive Jude","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Wehbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwafisayo","family":"Adebiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Bhavsar-Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-6821","authenticated-orcid":false,"given":"Itegbemie","family":"Obaitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"12323_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/j.semvascsurg.2021.02.010","volume":"34","author":"R Gupta","year":"2021","unstructured":"Gupta R, Woo K, Yi JA (2021) Epidemiology of end-stage kidney disease. Semin Vasc Surg 34(1):71\u201378","journal-title":"Semin Vasc Surg"},{"key":"12323_CR2","unstructured":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (ND) United States Renal Data System. In: 2024 USRDS Annual Data Report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda"},{"issue":"3","key":"12323_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/gast.1996.v111.pm8780583","volume":"111","author":"J Pauletzki","year":"1996","unstructured":"Pauletzki J et al (1996) Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology 111(3):765\u2013771","journal-title":"Gastroenterology"},{"issue":"3","key":"12323_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000336107","volume":"35","author":"P Sood","year":"2012","unstructured":"Sood P et al (2012) Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding. Am J Nephrol 35(3):216\u2013224","journal-title":"Am J Nephrol"},{"issue":"1","key":"12323_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","volume":"85","author":"V Chandrasekhara","year":"2017","unstructured":"Chandrasekhara V et al (2017) Adverse events associated with ERCP. Gastrointest Endosc 85(1):32\u201347","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"12323_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cgh.2009.09.029","volume":"8","author":"N Imai","year":"2010","unstructured":"Imai N et al (2010) High incidence of colonic perforation during colonoscopy in hemodialysis patients with end-stage renal disease. Clin Gastroenterol Hepatol 8(1):55\u201359","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"41","key":"12323_CR7","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.3748\/wjg.v24.i41.4691","volume":"24","author":"T Sawas","year":"2018","unstructured":"Sawas T et al (2018) End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 24(41):4691\u20134697","journal-title":"World J Gastroenterol"},{"issue":"6","key":"12323_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.20222","volume":"6","author":"MS Vell","year":"2023","unstructured":"Vell MS et al (2023) Association of statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality. JAMA Netw Open 6(6):e2320222","journal-title":"JAMA Netw Open"},{"issue":"1","key":"12323_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12876-023-03085-8","volume":"23","author":"DJ Huynh","year":"2023","unstructured":"Huynh DJ, Renelus BD, Jamorabo DS (2023) Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis. BMC Gastroenterol 23(1):450","journal-title":"BMC Gastroenterol"},{"key":"12323_CR10","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003322","author":"A Beran","year":"2025","unstructured":"Beran A et al (2025) Risk of post-polypectomy bleeding after colorectal endoscopic mucosal resection in patients with cirrhosis: a propensity-matched analysis of the US Collaborative Network. Am J Gastroenterol. https:\/\/doi.org\/10.14309\/ajg.0000000000003322","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"12323_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"12323_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2023.03.023","volume":"98","author":"VS Akshintala","year":"2023","unstructured":"Akshintala VS et al (2023) Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials. Gastrointest Endosc 98(1):1-6.e12","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"12323_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-1075-4080","volume":"52","author":"JM Dumonceau","year":"2020","unstructured":"Dumonceau JM et al (2020) ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 52(2):127\u2013149","journal-title":"Endoscopy"},{"issue":"11","key":"12323_CR14","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s10620-018-5112-6","volume":"63","author":"SB Kim","year":"2018","unstructured":"Kim SB, Kim KH, Kim TN (2018) Safety and efficacy of endoscopic retrograde cholangiopancreatography for choledocholithiasis in long-term dialysis: a propensity score analysis. Dig Dis Sci 63(11):3141\u20133146","journal-title":"Dig Dis Sci"},{"issue":"11","key":"12323_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/jpm12111883","volume":"12","author":"TY Park","year":"2022","unstructured":"Park TY et al (2022) Outcomes of endoscopic retrograde cholangiopancreatography in end-stage renal disease patients undergoing hemodialysis: a systematic review and pooled analysis. J Pers Med 12(11):1883","journal-title":"J Pers Med"},{"issue":"11","key":"12323_CR16","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.cgh.2024.11.014","volume":"23","author":"A Beran","year":"2024","unstructured":"Beran A et al (2024) Predictors of post-endoscopic retrograde cholangiopancreatography pancreatitis: a comprehensive systematic review and meta-analysis. Clin Gastroenterol Hepatol 23(11):1905\u20131916","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"12323_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jgh.12336","volume":"29","author":"Y Hori","year":"2014","unstructured":"Hori Y et al (2014) Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients. J Gastroenterol Hepatol 29(3):648\u2013652","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"12323_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","volume":"19","author":"D Kaw","year":"2006","unstructured":"Kaw D, Malhotra D (2006) Platelet dysfunction and end-stage renal disease. Semin Dial 19(4):317\u2013322","journal-title":"Semin Dial"},{"issue":"2","key":"12323_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0002-9343(94)90138-4","volume":"96","author":"ME Eberst","year":"1994","unstructured":"Eberst ME, Berkowitz LR (1994) Hemostasis in renal disease: pathophysiology and management. Am J Med 96(2):168\u2013179","journal-title":"Am J Med"},{"issue":"5","key":"12323_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1681\/ASN.V25961","volume":"2","author":"JW Lohr","year":"1991","unstructured":"Lohr JW, Schwab SJ (1991) Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol 2(5):961\u2013975","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"12323_CR21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","volume":"58","author":"MJ Sarnak","year":"2000","unstructured":"Sarnak MJ, Jaber BL (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58(4):1758\u20131764","journal-title":"Kidney Int"},{"issue":"24","key":"12323_CR22","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.3748\/wjg.v21.i24.7506","volume":"21","author":"JM Lee","year":"2015","unstructured":"Lee JM et al (2015) Risk factors of organ failure in cholangitis with bacteriobilia. World J Gastroenterol 21(24):7506\u20137513","journal-title":"World J Gastroenterol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12323-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:32:44Z","timestamp":1769023964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["12323"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12323-x","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. John J. Guardiola: Travel Support\u2014Boston Scientific, Olympus Corporation, Ovesco Endoscopy AG. Drs. Hussein Baydoun, Azizullah Beran, Aladdin Said Dahbour A, Mina Batarseh, Ujwala Pamidimukkala, Vikram R Rajagopalan, Eugene Nwankwo, Islam Mohamed, Clive Jude Miranda, Daryl Ramai, Hisham Wehbe, Oluwafisayo Adebiyi, Indira Bhavsar-Burke, and Itegbemie Obaitan have no relevant conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}